Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary

Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary Publisher

Bidaki R^{1, 2} ; Saghafi F³ ; Ahrari S⁴ ; Aghamollaii V⁵ ; Rahmani M⁶ ; Asadi A⁶

Show Affiliations

1. Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2. Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3. Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4. Department of Psychiatry and Behavioral Sciences, College of Medicine, Texas A&M University, Brownsville, TX, United States
5. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
6. Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Source: Clinical Case Reports Published:2021

Abstract

In the following, we report a therapeutic challenge faced by reduction in corticosteroid therapeutic dosage in a patient diagnosed with Hashimoto's encephalopathy (HE), which is equivalent to corticosteroid-responsive encephalopathy related to autoimmune thyroiditis and often misdiagnosed as neuropsychiatric status. The patient developed psychiatric symptoms. © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Style	Citing Format
MLA	Bidaki R, et al.. "Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary." Clinical Case Reports, vol. 9, no. 12, 2021, pp. -.
APA	Bidaki R, Saghafi F, Ahrari S, Aghamollaii V, Rahmani M, Asadi A (2021). Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary. Clinical Case Reports, 9(12), -.
Chicago	Bidaki R, Saghafi F, Ahrari S, Aghamollaii V, Rahmani M, Asadi A. "Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary." Clinical Case Reports 9, no. 12 (2021): -.
Harvard	Bidaki R et al. (2021) 'Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary', Clinical Case Reports, 9(12), pp. -.
Vancouver	Bidaki R, Saghafi F, Ahrari S, Aghamollaii V, Rahmani M, Asadi A. Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary. Clinical Case Reports. 2021;9(12):-.
BibTex	@article{ author = {Bidaki R and Saghafi F and Ahrari S and Aghamollaii V and Rahmani M and Asadi A}, title = {Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary}, journal = {Clinical Case Reports}, volume = {9}, number = {12}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Bidaki R AU - Saghafi F AU - Ahrari S AU - Aghamollaii V AU - Rahmani M AU - Asadi A TI - Challenges in Corticosteroid Dose Regulation in a Patient With Autoimmune Thyroid Disease and Neuropsychiatric Syndrome: A Running Commentary JO - Clinical Case Reports VL - 9 IS - 12 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract